NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes
Type 2 diabetes mellitus (T2DM), accounting for 90–95% cases of diabetes, is characterized by chronic inflammation. The mechanisms that control inflammation activation in T2DM are largely unexplored. Inflammasomes represent significant sensors mediating innate immune responses. The aim of this work...
Main Authors: | Ilona M. Gora, Anna Ciechanowska, Piotr Ladyzynski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/2/314 |
Similar Items
-
NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis
by: Wan Z, et al.
Published: (2019-09-01) -
Inflammation triggered by the NLRP3 inflammasome is a critical driver of diabetic bladder dysfunction
by: Francis M. Hughes, et al.
Published: (2022-11-01) -
The role of NLRP3 inflammasome in type 2 inflammation related diseases
by: Shenming Xu, et al.
Published: (2024-12-01) -
Sterile inflammation and the NLRP3 inflammasome in cardiometabolic disease
by: Sungji Cho, et al.
Published: (2023-10-01) -
Palmitic acid activates NLRP3 inflammasome and induces placental inflammation during pregnancy in mice
by: Michiya SANO, et al.
Published: (2020-02-01)